Winn-Dixie Announces Community Donation Program to Benefit Ochsner Cancer Institute

Winn-Dixie announces the launch of a community donation program during the month of October to raise funds for the Ochsner Cancer Institute. All money raised will help the renowned institution in providing exceptional treatment and health care to individuals living with cancer and offer essential support and resources to families of cancer patients.

Now through Oct. 26, Winn-Dixie customers can round up their grocery total at checkout or make donations of their choice at the register in all Louisiana stores to support local patients at the Ochsner Cancer Institute. Ochsner’s cancer centers across the state have been dedicated to cancer research and new cancer treatment development for more than 70 years. The funds raised will directly benefit the Ochsner Cancer Institute with a goal of positively impacting the quality of life of patients by offering world-class care at one of the top cancer facilities in the Gulf South.

Joey Medina, Regional Vice President at Winn-Dixie, said, “Winn-Dixie has a 65-year history of serving our communities along the Gulf Coast – a region known for resilience in the face of adversity. We are honored to continue our support of the Ochsner Cancer Institute as they strive to offer quality service and insurmountable strength to people when they need it most. Winn-Dixie commends Ochsner for its devotion to patients and families, and we stand with the institution in its tremendous dedication to making our communities stronger.”

Winn-Dixie is committed to partnering with organizations like the Ochsner Cancer Institute, one of the largest comprehensive cancer centers in the Gulf South region. The health system provides the personalized care and state-of the-art treatment critically needed to build healthier communities. Ochsner Cancer Institute aims to provide the highest level of care in the region to patients by offering advanced technology and treatment options so that patients do not have to leave the state for high-quality cancer care. Ochsner’s integrative oncology program underscores an important focus of the institute’s multidisciplinary approach: the social, physical and emotional impacts of cancer treatment. At the Ochsner Cancer Institute, disease-specific teams collaborate to deliver outstanding outcomes and help patients and their families navigate this complex disease and its treatment.

Shon Cowan Baker, PhD, Vice President for Philanthropy at Ochsner Health, said, “The Ochsner Cancer Institute believes in offering high quality care close to home. Thanks to the ongoing support from Winn-Dixie and the communities we serve, Ochsner Cancer Institute is able to deliver the lifesaving care needed to build a healthier community – for today and generations to come.”

Winn-Dixie is honored to continue its longstanding partnership with Ochsner Health, an organization that shares the grocer’s dedication to caring for the community during challenging times. Since 2017, Winn-Dixie and its generous customers have donated more than $320,000 to Ochsner Health to support the wellbeing of patients and families along the Gulf Coast.

Additionally, Winn-Dixie and its parent company, Southeastern Grocers, together with the donations from generous customers, recently raised more than $112,000 to support hunger relief. This donation is in addition to the grocer’s charitable foundation’s contribution of $150,000 to Feeding America® network food banks for Hunger Action Month®, including $25,000 to Second Harvest Food Bank in New Orleans.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version